Detalhe da pesquisa
1.
Correction: Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
PLoS Pathog
; 17(12): e1010148, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890427
2.
Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
PLoS Pathog
; 17(2): e1009352, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33635919
3.
Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka.
J Immunol
; 207(11): 2681-2687, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750205
4.
Immune responses to Sinopharm/BBIBP-CorV in individuals in Sri Lanka.
Immunology
; 167(2): 275-285, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35758860
5.
Comparison of the immunogenicity of five COVID-19 vaccines in Sri Lanka.
Immunology
; 167(2): 263-274, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751563
6.
Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222.
Clin Exp Immunol
; 208(3): 323-331, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641142
7.
Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.
J Virol
; 94(4)2020 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31748388
8.
A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
J Gen Virol
; 100(3): 431-445, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30714896
9.
Characterization of Influenza Virus Pseudotyped with Ebolavirus Glycoprotein.
J Virol
; 92(4)2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29212933
10.
Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2.
Nat Commun
; 14(1): 311, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36658148
11.
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals.
Immun Inflamm Dis
; 10(4): e592, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349749
12.
A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern.
Commun Med (Lond)
; 2: 36, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603265
13.
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2.
Theranostics
; 12(1): 1-17, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34987630
14.
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac).
Sci Rep
; 12(1): 1727, 2022 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110645
15.
Persistence of immune responses to the Sinopharm/BBIBP-CorV vaccine.
Immun Inflamm Dis
; 10(6): e621, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35634958
16.
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals.
medRxiv
; 2021 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34729569
17.
Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka.
Front Public Health
; 9: 724398, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34869146
18.
Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers.
Nat Commun
; 12(1): 4617, 2021 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34326317
19.
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.
bioRxiv
; 2021 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758862
20.
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.
iScience
; 24(10): 103144, 2021 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34545347